Proceedings of 32nd Annual General Meeting of the Company

Ref No. PPL/BSE/2026-27 Date: 29-09-2026 The Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Scrip Code :540359 Scrip ID :PARMAX Sub: Proceedings of 32nd Annual General Meeting of the Company held on Tuesday, September 29, 2026. Dear Sir / Madam, Pursuant to Regulation 30 read with Para A (13) of Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (“Listing Regulation”) we hereby wish to inform you that the 32nd Annual General Meeting (“AGM”) of the members of the Company was held on Tuesday, September 29, 2026 at 3.30 p.m. through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The deemed venue of the AGM was the Registered Office of the Company situated at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Rajkot, Hadamtala, Gujarat, India, 360311. The summary of proceedings has been enclosed herewith. Kindly take the same on record. Thanking you, Yours faithfully, For Parmax Pharma Limited Umang Gosalia Managing Director DIN: 05153830 Encl: As above Summary of Proceedings of 32nd Annual General Meeting of Parmax Pharma Limited held on Tuesday, September 29, 2026 I. Date, time and Venue of the Meeting: The 32nd Annual General Meeting (“AGM”) of Parmax Pharma Limited (“the Company”) was held on Tuesday, September 29, 2026 at 3.30 noon, through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”), in compliance with the applicable provision of the Companies Act, 2013, Secretarial Standards – 2, Circular No. 20/2020 dated May 05, 2020, Circular No. 02/2021 dated January 13, 2021 and Circular No. 10/2022 dated December 28, 2022, Circular No. 09/2023 dated September 25, 2023, Circular 09/2024 dated September 19 2024 and No. 03/2025 dated 22nd September, 2025 (collectively referred to as 'MCA Circulars') and Securities and Exchange Board of India (“SEBI”) Circular no. SEBI/HO/CFD/ CMD1/CIR/P/2020/79 dated May 12, 2020, Circular no. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated January 15, 2021, Circular No SEBI/HO/CFD/CMD2/CIR/P/2022/62 dated May 13, 2022 , SEBI/HO/CFD/PoD2/P/CIR/2023/4 dated January 5, 2023 and Circular No SEBI / HO / CFD / CMD2/CIR/ P/2023/167 dated October 7, 2023 and SEBI/ HO/ CFD/ CFDPoD-2/ P/ CIR/ 2024/ 133 dated October 3, 2024 (collectively referred to as SEBI Circulars). The deemed venue of the AGM was the Registered Office of the Company situated at Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Rajkot, Hadamtala, Gujarat, India, 360311 II. Brief Details of items deliberated and result thereof: Mr. Umang Gosalia, Managing Director appointed as Chairman and chaired the Annual General Meeting and authorised CS Riddhesh Jain to conduct the meeting, he welcomed all the members and auditors, joining the virtual meeting in the 32nd Annual General Meeting and introduced other Directors who have attended the meeting virtually from the Board Room. The number of shareholders as on the cut-off date i.e.22nd September, 2026 was shareholders attended the meeting through video conferencing. The Chairman called the meeting to order as requisite quorum was present. The meeting was also attended by Mr. Dhiren Chandulal Shah, Non-Executive Director, Mr. Sunil Chinubhai Shah, Non- Executive Director, Mr. Pradeep Gosalia, Non- Executive Director, Mr. Nikhil Uchat, Independent Director and Chairman of Audit Committee and Nomination and Remuneration Committee, and Mr. Samsad Alam Khan, Secretarial Auditor and Scrutinizer for the Meeting. The Chairman authorised CS Riddhesh Jain – Authorized Representative to continue the proceedings of the AGM. The Notice calling the 32nd AGM was taken as read with permission of the members present. The members were informed that there were no observations or other remarks made by the Auditors in their Report on the Financial Statements for the financial year ended March 31, 2026 and therefore the reports are self-explanatory and same is not required to be read. The observations in the secretarial audit report does not have any material adverse effect on the functioning of the Company and therefore not required to be read. The Members were informed that pursuant to the provision of the Companies Act, 2013 and Regulation 44 of Listing Regulation the Company had engaged the Services of Purva Sharegistry India Private Limited (Purva) as the authorised agency to provide remote e-voting facility & e-voting facility during the AGM. The remote e-voting facility commenced at September 26, 2026 at 09:00 A.M. and ends on September 28, 2026 at 05:00 P.M. He further informed that all the statutory registers / documents were made available for inspection at the registered office throughout the meeting, and can be inspected by sending request. It was further informed that the Company had provided the facility of e-voting during the AGM also. Members who had not exercised their right to vote through remote e-voting were entitled to vote during the meeting and 15 minutes thereafter. The Consolidated Voting Results and the Report of the Scrutinizer will be displayed on the website of the Company i.e. www.parmaxpharma.com, Purva Website i.e. https://evoting.purvashare.com and will also be intimated to the BSE Limited within stipulated time. The following items of business as set out in the Notice calling the meeting were then taken up and put for consideration: Ordinary Business: 1. To consider and adopt the Audited Standalone Financial Statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon; (Ordinary Resolution) 2. To appoint Mr. Umang Gosalia (DIN: 05153830), who retires by rotation and being eligible offers himself for re-appointment (Ordinary Resolution), 3. To approve the appointment of Mr. Dhiren Shah (Din: 00255333) as a Non-Executive Director of the Company. (Ordinary Resolution), 4. To approve the Appointment of Mr. Sunil Chinubhai Shah (DIN: 11888388) as a Non-Executive Director of the Company. (Ordinary Resolution) 5. To approve the Appointment of Mrs. Anjana Paresh Shah (DIN: 00845784) as an Independent Director of the Company (Ordinary Resolution) 6. To Approve the Appointment of Mr. Ashish Atmaram Shah, (DIN-06873593) as a Non- Executive and Independent Director of the Company. (Ordinary Resolution) Thereafter, the Members who had registered themselves as speakers, were called and appeared to raise their queries, queries were replied to the queries raised. Since all the business mentioned in the notice calling AGM were transacted, the Chairman declared the meeting as concluded with thanks. The Meeting concluded at 3.52 p.m. (excluding time allowed for e-voting.) Thanking you, For Parmax Pharma Limited Umang Gosalia Managing Director DIN: 05153830